Clinical Trials Browser

Terminated × Carcinoma, Non-Small-Cell Lung × venetoclax × Clear all

NCT04274907 2021-02-11

A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasms